259 related articles for article (PubMed ID: 28668194)
21. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.
Telehany SM; Humby MS; McGee TD; Riley SP; Jacobs A; Rizzo RC
Biochemistry; 2020 Oct; 59(39):3709-3724. PubMed ID: 32876433
[TBL] [Abstract][Full Text] [Related]
22. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
[TBL] [Abstract][Full Text] [Related]
23. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
Anasir MI; Ramanathan B; Poh CL
Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
[TBL] [Abstract][Full Text] [Related]
24. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
Parkinson T; Pryde DC
Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
[TBL] [Abstract][Full Text] [Related]
25. Identification of sequence motifs involved in Dengue virus-host interactions.
Asnet Mary J; Paramasivan R; Shenbagarathai R
J Biomol Struct Dyn; 2016; 34(3):676-87. PubMed ID: 25905427
[TBL] [Abstract][Full Text] [Related]
26. Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry.
Pascual MJ; Merwaiss F; Leal E; Quintana ME; Capozzo AV; Cavasotto CN; Bollini M; Alvarez DE
Antiviral Res; 2018 Jan; 149():179-190. PubMed ID: 29031833
[TBL] [Abstract][Full Text] [Related]
27. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
28. Targeting a conserved pocket (n-octyl-β-D-glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitors.
Naresh P; Selvaraj A; Shyam Sundar P; Murugesan S; Sathianarayanan S; Namboori P K K; Jubie S
J Biomol Struct Dyn; 2022 Jul; 40(11):4866-4878. PubMed ID: 33345726
[TBL] [Abstract][Full Text] [Related]
29. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
[TBL] [Abstract][Full Text] [Related]
30. Targeting the dengue β-OG with serotype-specific alkaloid virtual leads.
Gangopadhyay A; Chakraborty HJ; Datta A
J Mol Graph Model; 2017 May; 73():129-142. PubMed ID: 28279821
[TBL] [Abstract][Full Text] [Related]
31. Carbohydrate-related inhibitors of dengue virus entry.
Hidari KI; Abe T; Suzuki T
Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
[TBL] [Abstract][Full Text] [Related]
32. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
33. Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors.
Hernandez J; Hoffer L; Coutard B; Querat G; Roche P; Morelli X; Decroly E; Barral K
Eur J Med Chem; 2019 Jan; 161():323-333. PubMed ID: 30368131
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents.
Lin C; Yu J; Hussain M; Zhou Y; Duan A; Pan W; Yuan J; Zhang J
Antiviral Res; 2018 Jan; 149():95-105. PubMed ID: 29129706
[TBL] [Abstract][Full Text] [Related]
35. Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase.
Cannalire R; Tarantino D; Astolfi A; Barreca ML; Sabatini S; Massari S; Tabarrini O; Milani M; Querat G; Mastrangelo E; Manfroni G; Cecchetti V
Eur J Med Chem; 2018 Jan; 143():1667-1676. PubMed ID: 29137867
[TBL] [Abstract][Full Text] [Related]
36. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn Kinases.
Vincetti P; Caporuscio F; Kaptein S; Gioiello A; Mancino V; Suzuki Y; Yamamoto N; Crespan E; Lossani A; Maga G; Rastelli G; Castagnolo D; Neyts J; Leyssen P; Costantino G; Radi M
J Med Chem; 2015 Jun; 58(12):4964-75. PubMed ID: 26039671
[TBL] [Abstract][Full Text] [Related]
38. Identification of small molecule inhibitors targeting the Zika virus envelope protein.
Pitts J; Hsia CY; Lian W; Wang J; Pfeil MP; Kwiatkowski N; Li Z; Jang J; Gray NS; Yang PL
Antiviral Res; 2019 Apr; 164():147-153. PubMed ID: 30771406
[TBL] [Abstract][Full Text] [Related]
39. Strategies for development of Dengue virus inhibitors.
Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents.
Lee JC; Tseng CK; Lin CK; Tseng CH
Eur J Med Chem; 2017 Dec; 141():282-292. PubMed ID: 29031073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
